PCCOF
Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. The company was incorporated in 1928 and is headquartered in Osaka, Japan. Paltac Corporation is a subsidiary of MediPal Holdings Corporation.
PCCOF (PCCOF) - Net Assets
Latest net assets as of September 2025: $297.21 Billion USD
Based on the latest financial reports, PCCOF (PCCOF) has net assets worth $297.21 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($530.65 Billion) and total liabilities ($233.44 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $297.21 Billion |
| % of Total Assets | 56.01% |
| Annual Growth Rate | 5.68% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1.57 |
PCCOF - Net Assets Trend (2022–2025)
This chart illustrates how PCCOF's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PCCOF (2022–2025)
The table below shows the annual net assets of PCCOF from 2022 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $287.67 Billion | +3.49% |
| 2024-03-31 | $277.96 Billion | +7.03% |
| 2023-03-31 | $259.69 Billion | +6.55% |
| 2022-03-31 | $243.74 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to PCCOF's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12.8% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $25.64 Billion | 8.91% |
| Other Components | $262.03 Billion | 91.09% |
| Total Equity | $287.67 Billion | 100.00% |
PCCOF Competitors by Market Cap
The table below lists competitors of PCCOF ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
North West Company Inc
TO:NWC
|
$1.34 Billion |
|
Pci-Suntek Technology Co Ltd
SHG:600728
|
$1.34 Billion |
|
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380
|
$1.34 Billion |
|
Virbac SA
PINK:VRBCF
|
$1.34 Billion |
|
Parkway Life Real Estate Investment Trust
PINK:PRKWF
|
$1.34 Billion |
|
StubHub Holdings, Inc.
NYSE:STUB
|
$1.33 Billion |
|
Central New Energy Holding Group Limited
F:H4M1
|
$1.33 Billion |
|
Shanxi Taigang Stainless Steel Co Ltd
SHE:000825
|
$1.33 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PCCOF's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 277,958,000,000 to 287,666,000,000, a change of 9,708,000,000 (3.5%).
- Net income of 22,864,000,000 contributed positively to equity growth.
- Dividend payments of 6,204,000,000 reduced retained earnings.
- Share repurchases of 4,999,000,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $22.86 Billion | +7.95% |
| Dividends Paid | $6.20 Billion | -2.16% |
| Share Repurchases | $5.00 Billion | -1.74% |
| Other Changes | $-1.95 Billion | -0.68% |
| Total Change | $- | 3.49% |
Book Value vs Market Value Analysis
This analysis compares PCCOF's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-03-31 | $3878.28 | $48.10 | x |
| 2023-03-31 | $4132.19 | $48.10 | x |
| 2024-03-31 | $4422.79 | $48.10 | x |
| 2025-03-31 | $4664.14 | $48.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PCCOF utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.95%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.92%
- • Asset Turnover: 2.34x
- • Equity Multiplier: 1.76x
- Recent ROE (7.95%) is above the historical average (7.71%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 8.06% | 1.88% | 2.33x | 1.84x | $-4.73 Billion |
| 2023 | 7.41% | 1.74% | 2.32x | 1.84x | $-6.72 Billion |
| 2024 | 7.42% | 1.79% | 2.32x | 1.78x | $-7.16 Billion |
| 2025 | 7.95% | 1.92% | 2.34x | 1.76x | $-5.90 Billion |
Industry Comparison
This section compares PCCOF's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,984,957,715
- Average return on equity (ROE) among peers: 1.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PCCOF (PCCOF) | $297.21 Billion | 8.06% | 0.79x | $1.34 Billion |
| Acme United Corporation (ACU) | $25.35 Million | 10.15% | 0.96x | $136.27 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $4.20 Billion | 15.71% | 0.65x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.18 Billion | 11.18% | 0.32x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $8.66 Billion | -8.65% | 0.19x | $1.01 Billion |
| Bemax Inc (BMXC) | $1.50K | -133.51% | 1.67x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $223.65 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $12.40 Million |
| Church & Dwight Company Inc (CHD) | $3.86 Billion | 19.60% | 1.22x | $23.18 Billion |
| Colgate-Palmolive Company (CL) | $1.92 Billion | 101.83% | 4.19x | $68.12 Billion |